Form D · Biotechnology
Valorem Biotech LLC
Austin, TX · CIK 0002071840
Offering snapshot reported Jun 10, 2025 · SEC filing
- Reported sold
- $141K Offering amount: $141K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- May 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 10, 2025 | Initial | $141,150 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-548437
Source: Form D, filed Jun 10, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gavin Moler | Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3616 Pawnee Pass S.
Austin, TX, 78738
Austin, TX, 78738